Advanced search
Publication Cover
Current Medical Research and Opinion Volume 35, 2019 - Issue sup3: Management of Patients with Heart Failure: Italian "Field Practice" Experience on Sacubitril/Valsartan
Submit an article Journal homepage
374
Views
6
CrossRef citations to date
0
Altmetric
Cardiovascular

Effects of sacubitril/valsartan on B-type natriuretic peptide circulating levels and loop diuretic dose in a case series of stabilized heart failure patients with left ventricular ejection fraction ≤35%

Nicola Riccardo PuglieseDepartment of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy; ;Cardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;
,
Iacopo FabianiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy; ;Department of Surgical, Medical, Molecular and Critical Area Pathology, University of Pisa, Pisa, Italy
,
Viola ZywickiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;
,
Matteo MazzolaCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;
,
Andreina D’AgostinoCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;
,
Gian Giacomo GaleottiCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy;
&
Frank Lloyd DiniCardiac, Thoracic and Vascular Department, University of Pisa, Pisa, Italy; Correspondence[email protected]
 show all
Pages 13-18 | Received 21 Jul 2018, Accepted 14 Mar 2019, Published online: 07 May 2019

References

  • Lin DC, Diamandis EP, Januzzi JL Jr, et al. Natriuretic peptides in heart failure. Clin Chem. 2014;60:1040–1046.
  • McMurray JJ, Packer M, Desai AS, et al. Angiotensin–neprilysin inhibition versus enalapril in heart failure. N Engl J Med. 2014;371:993–1004.
  • Ponikowski P, Voors AA, Anker SD, et al. 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2016;37:2129–2200.
  • Yancy CW, Jessup M, Bozkurt B, et al. 2017 ACC/AHA/HFSA focused update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. J Am Coll Cardiol. 2017;70:776–803.
  • Lippi G, Sanchis-Gomar F. Monitoring B-type natriuretic peptide in patients undergoing therapy with neprilysin inhibitors. An emerging challenge? Int J Cardiol. 2016;219:111–114.
  • Maisel AS, Daniels LB, Anand IS, et al. Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy. Postgrad Med. 2018;130:299–307.
  • Vardeny O, Claggett B, Packer M, et al. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial. Eur J Heart Fail. 2016;18:1228–1234.
  • Lang RM, Badano LP, Mor-Avi V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16:233–270.
  • Simioniuc A, Carluccio E, Ghio S, et al. Echo and natriuretic peptide guided therapy improves outcome and reduces worsening renal function in systolic heart failure: an observational study of 1137 outpatients. Int J Cardiol. 2016;224:416–423.
  • Dini FL, Ghio S, Klersy C, et al. Effects on survival of loop diuretic dosing in ambulatory patients with chronic heart failure using a propensity score analysis. Int J Clin Pract. 2013;67:656–664.
  • Grande D, Leone M, Rizzo C, et al. A multiparametric approach based on NT-proBNP, ST2, and galectin3 for stratifying one year prognosis of chronic heart failure outpatients. J Cardiovasc Dev Dis. 2017;4:9.
  • Woods DR, Mellor A, Begley J, et al. Brain natriuretic peptide and NT-proBNP levels reflect pulmonary artery systolic pressure in trekkers at high altitude. Physiol Res. 2013;62:597–603.
  • Vavera Z, Vojáček J, Pudil R, et al. NT-proBNP levels on admission predicts pulmonary hypertension persistence in patients with acute pulmonary embolism. Cor Vasa. 2012;54:e27–e31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.